Nvidia Pays $13 Billion for Hugging Face, Turning AI’s Open-Source Heartbeat Into a Corporate Asset
Nvidia acquires Hugging Face for $13 billion, ending the open-source AI platform’s run as an independent force in machine learning.
Nvidia Pays $13 Billion for Hugging Face, Turning AI’s Open-Source Heartbeat Into a Corporate Asset
Nvidia acquires Hugging Face for $13 billion, ending the open-source AI platform’s run as an independent force in machine learning.
A New Tool Lets You See Exactly Which Data Brokers Are Selling Your Personal Information
A new free service exposes which data brokers are trading your personal data — and gives you a direct path to opt out.
Oura Files for US IPO as Annual Revenue Climbs Past $500 Million
Oura’s IPO filing reveals rapid revenue growth, a $5.2B valuation, and ambitions to reshape the wearable health tech market.
Forget Consciousness: The Real Question Is Whether AI Has Crossed Into Something Like Life
A provocative new argument shifts the AI sentience debate away from consciousness entirely — and toward whether AI systems already qualify as alive.
When AI Does the Hard Work, Who Learns the Hard Lessons?
AI tools are making engineers faster — but experts warn the productivity gains may be quietly hollowing out deep technical expertise.
A Mass Diarrhea Outbreak in 150 Monkeys Accidentally Generated a Treasure Trove of Vaccine Science
When 150 research primates fell ill with diarrhea, scientists turned the crisis into a rare, expansive dataset on immune response and vaccine efficacy.
Crusoe Hits $30 Billion Valuation After Closing a $3 Billion Funding Round
AI infrastructure company Crusoe has reportedly closed a $3 billion funding round, catapulting its valuation to $30 billion.
Startup Acquisitions in 2026: Every Deal Reshaping the Tech Landscape So Far
Calcalist’s running list of every Israeli startup M&A in 2026 shows a market heating up across AI, cyber, and deep tech.
CDC Quietly Kept Counting Measles Deaths After RFK Jr. Allegedly Ordered the Data Scrubbed
RFK Jr. reportedly directed CDC officials to remove measles death data from public records. The agency kept counting anyway, in secret.
With $36 Million in the Bank, Remepy Is Taking AI-Guided Parkinson’s Therapy Toward Its Pivotal Trial
Israeli biotech Remepy closes a $36M Series A to fund Phase III trials of its AI-driven Parkinson’s disease treatment platform.